Long term Zoloft use may increase diabetes risk
A new study published in the American Journal of Psychiatry has found that patients who use the antidepressant Zoloft for an extended period of time may be more likely to develop type II diabetes. According to the study, users of antidepressants such as Zoloft were 84% more likely to develop diabetes after two years than patients who used did not… read more »
Zoloft class action lawsuit heads to St. Louis court
A federal judge has ruled that a Zoloft class action lawsuit filed against the drug’s manufacturer will be heard in a St. Louis court. The lawsuit alleges that Pfizer Inc. failed to properly warn patients that women who use Zoloft during pregnancy are at an increased risk of giving birth to a child with severe birth defects. read more »
Zoloft linked to increased diabetes risk
The antidepressant Zoloft has been linked to an increased risk of diabetes in patients who took the drug over an extended period of time, according to a study published in the American Journal of Psychiatry. Researchers found that patients taking Zoloft or other antidepressants known as selective serotonin reuptake inhibitors (SSRIs) for more than two years had an 84% increased… read more »
Study links Zoloft to additional birth complications
A study published in the Archives of General Psychiatry has uncovered a link between additional birth complications and antidepressants such as Zoloft. The research was conducted in the Netherlands over several years and involved nearly 8,000 women. Several studies had previously linked Zoloft and other antidepressants called selective serotonin reuptake inhibitors (SSRIs) to an increased risk of birth defects. read more »
FDA issues antidepressant heart problems warning
The Food and Drug Administration is adding information to its recent warning on Celexa, an antidepressant in a class of drugs known as selective serotonin reuptake inhibitors (SSRIs), which also includes Zoloft and Paxil. The FDA will add dosage suggestions to the recently-added warning of abnormal and potentially fatal heart electrical activity and rhythms tied to Celexa. read more »
Zoloft birth defects lawsuit filed in Florida
A Zoloft birth defects lawsuit has been filed in Florida against the manufacturer of the antidepressant drug. Stephanie Williams alleges that Pfizer failed to properly warn patients that taking Zoloft during pregnancy could lead to an increased risk of serious birth defects. read more »
Louisiana couple files Zoloft birth defects lawsuit
A Louisiana couple has filed a Zoloft lawsuit against the manufacturer of the antidepressant. In their lawsuit, Terry and Nelda Rolling allege that Pfizer failed to warn patients about the increased risks of birth defects among children who are born to women who use Zoloft while pregnant. read more »
Class action Zoloft lawsuit filed against drugmaker
A Zoloft class action lawsuit was filed in Missouri against the manufacturer of the drug. Shainyah Lancaster and several other mothers allege that Pfizer Inc. hid information that linked Zoloft to an increased risk of birth defects. read more »
California couple files Zoloft lawsuit after infant’s death
A California couple has filed a Zoloft lawsuit against the drug’s manufacturer after the death of their infant daughter from congenital heart defects. Farah and Trevor Hartley allege that Pfizer withheld information that taking Zoloft during pregnancy could increase the risks of birth defects. read more »
British study links Zoloft during third trimester to increased birth defects risk
A study published in the British Medical Journal (BMJ) has found that women who take Zoloft after the 20th week of pregnancy are more than twice as likely as non-users to give birth to a child with a serious type birth defect known as persistent pulmonary hypertension of the newborn (PPHN). The study also found an increased risk of PPHN… read more »